In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

BCAL Diagnostics Limited Balance Sheet Statement - Assets

As of 30 Jun 2025, The total current assets of BCAL Diagnostics Limited (ASX:BDX) was around $7,195,254 which consisted of $4,522,756 of Cash, no Inventory and $6,934 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$4,522,756
Current assets
$7,195,254
Total assets
$9,908,929

The latest balance sheet of BCAL Diagnostics Limited also showed $2,713,675 of Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $9,908,929.

BCAL Diagnostics Limited Balance Sheet Statement - Liabilities

BDX's latest annual results shows the balance sheet has $548,425 of Accounts Payable. Also there were $2,378,943 of Short/Long term debt, $122,148 of Long term debt, no Other Current liabilities and $3,107,621 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$548,425
Current liabilities
$3,107,621
Total liabilities
$3,688,012

As per the 30 Jun 2025's annual report of BCAL Diagnostics Limited, the total liabilities were $3,688,012.

BDX Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of BCAL Diagnostics Limited showed the total stock holder equity was $6,220,917 which consisted of $33,834,690 of Common stocks, $-28,081,285 of Retained earnings and no Other stock holder equity.

BDX Balance Sheet Statement History

Following table shows the history of balance sheet for BCAL Diagnostics Limited (BDX).

30 Jun 2025 30 Jun 2024 30 Jun 2023 30 Jun 2022
Cash 4,522,756 6,472,988 3,174,092 5,571,417
Net Receivables 6,934 34,551 1,112 13,117
Inventory - - - -
Total Current Assets 7,195,254 9,337,642 6,200,280 10,455,059
Property Plant Equipment 2,713,675 2,927,964 2,099,225 84,821
Good Will - - - -
Intangible Assets - - - -
Other Assets - - - -
Deferred Long Term Asset Charges - - - -
Total Assets 9,908,929 12,265,606 8,299,505 10,539,880
Accounts Payable 548,425 740,188 1,581,349 277,192
Short/Long Term Debt 2,378,943 1,523,853 1,061,365 -
Other Current Liabilities - - - -
Long Term Debt 122,148 400,221 - -
Other Liabilities - - - -
Total Current Liabilities 3,107,621 2,595,546 2,260,608 950,423
Total Liabilities 3,688,012 3,677,181 3,157,399 950,423
Common Stock 33,834,690 28,895,408 19,281,951 18,871,951
Retained Earnings -28,081,285 -20,975,961 -14,614,925 -9,553,170
Treasury Stock - - - -
Other Stockholder Equity - - - -
Total Stockholder Equity 6,220,917 8,588,425 5,213,765 9,639,840
Net Tangible Assets 6,220,917 8,588,425 5,213,765 9,639,840

BCAL Diagnostics Limited (ASX:BDX) Balance Sheet Statement FAQ

1. How much Cash BCAL Diagnostics Limited has on their balance sheet?

As of 30 Jun 2025, BCAL Diagnostics Limited (ASX:BDX) has $4,522,756 of Cash.

2. What's the long term debt of BCAL Diagnostics Limited?

As per the latest Balance sheet of BCAL Diagnostics Limited (ASX:BDX), it has $122,148 of Long term debt.

3. How much share holder equity does BCAL Diagnostics Limited has?

The BCAL Diagnostics Limited (ASX:BDX)'s balance sheet shows that it has $6,220,917 of Total stock holder equity.